Skip to content
ALL Metrics
-
Views
2
Downloads
Get PDF
Get XML
Cite
Export
Track
▬
✚
Research Article

Are Maternal Decision Aids sustained in the centre where they had been found to be effective?

[version 1; peer review: awaiting peer review]
PUBLISHED 28 Oct 2026
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS AWAITING PEER REVIEW

Abstract

Background

Decision aids (DAs) improve informed choice, reduce decisional conflict, and support shared decision-making. Although their effectiveness has been demonstrated repeatedly in randomised trials, little is known about whether these tools survive beyond the research programmes that created them. We therefore examined the post-study availability and sustainability of maternity decision aids identified in a systematic review.

Methods

We undertook a follow-up evaluation of patient-directed maternal decision aids identified from a published systematic review. For each tool, we assessed whether it remained retrievable in its original or equivalent form and whether it continued to be used in routine clinical practice. Information was obtained from published sources, supplementary materials, direct correspondence with study authors, and, where necessary, the clinical services in which the tools had originally been implemented. Reported reasons for discontinuation were interpreted using the Non-adoption, Abandonment, Scale-up, Spread and Sustainability (NASSS) framework.

Results

Five patient-directed decision aids met the inclusion criteria. Author correspondence was obtained for all five. At the time of assessment, one decision aid was reported to remain in routine clinical use, while four were reported not to be in routine use. Respondent-reported explanations included funding and licensing limitations, lack of organisational ownership or stewardship, and difficulty maintaining or updating tools and prediction models. These reasons were deductively mapped to NASSS domains.

Conclusions

This follow-up evaluation suggests that maintaining maternity decision aids after their original evaluation can be challenging. Investigator reports identified recurrent vulnerabilities involving funding, ownership, governance, licensing, and updating. Because current use and reasons for discontinuation were based primarily on investigator correspondence rather than systematic verification with implementing organisations, these findings should be interpreted as descriptive and hypothesis-generating.

Plain Language Summary

When pregnant women face choices about their care, such as whether to try for a vaginal birth after a previous caesarean section, they may be offered a ‘decision aid’. This is a leaflet, website or computer program that explains the options and their risks and benefits, and helps women think about what matters most to them. Research studies have shown that decision aids help women feel better informed and more confident about their choices. However, little is known about what happens to these tools once the research study has finished.

We looked at five decision aids for pregnant women that had been tested in earlier studies in the USA, the UK, the Netherlands, and Canada and Spain. For each one, we checked whether the tool could still be found, and we contacted the researchers who developed it to ask whether it was still being used in hospitals.

Only one of the five decision aids, developed in the Netherlands, was reported to still be in routine use, and even this tool needed updating. The other four were no longer being used. The researchers told us this was mainly because funding ran out when the study ended, no organisation took responsibility for looking after the tool, there were licensing problems, or the tool could not be updated when medical knowledge changed.

Our findings suggest that showing a decision aid works is not enough on its own. Plans for who will own, pay for and update a decision aid should be made from the start, so that women can continue to benefit from it.

Keywords

Decision aids, Maternity care, Sustainability, Implementation gap

Background

Patient choice is a fundamental aspect of maternity care because of the extensive range of choices that confront service users from conception to birth and beyond. As a woman approaches birth, for example, choices include place of birth, pain relief, induction versus expectant management after term, mode of birth (planned caesarean versus vaginal delivery), along with potential management of breech presentation, previous caesarean, and a putatively large baby.1–3

In all these circumstances, women must assimilate a large amount of information to make a decision in accordance with their values (preferences). Decision aids (DA) are recommended to help service users make decisions that align as closely as possible with their values; they help people understand options, evaluate risks and benefits, and thus make choices aligned with their preferences.4

DAs have been studied as an aid to choice in the third trimester of pregnancy.2,3 In this study, we evaluate the sustainability of DAs, and we ask the question - were DAs sustained in the sites where they had been shown to be effective?

More specifically, we examine:

  • 1) Whether the original DA could be retrieved either from the original article (hyperlink or the supplementary material) or from the author, and

  • 2) Whether the DA (or a later version of the DA) is still in use in the location(s) where the original study was conducted

Methods

Patient and public involvement

Patients and the public were not involved in this study. The study was a desk-based follow-up of published decision aids that used published literature and correspondence with the original study investigators; no patients were recruited and no patient-level data were collected. Patients and the public were therefore not involved in developing the research question, in the design or conduct of the study, in the choice of outcome measures (retrievability and continued clinical use of each decision aid), or in recruitment, as there were no participants to recruit. Patients and the public were not involved in choosing the methods or agreeing plans for dissemination. The findings, together with the plain language summary, will be shared with patient and public contributors through the NIHR Midlands Patient Safety Research Collaboration.

Study selection

We based our study on Cockburn’s previous systematic review of decision aids in maternal health.5 Cockburn included a wide range of decision aids, including prompts/action suggestions aimed at clinicians. We removed these clinician-facing aids, retaining only those designed to support service user choice between alternative courses of action.

Data extraction

For each included study, basic descriptive information about the decision aid was extracted. This information included the study design, clinical context, the tool’s format (digital application, computer interface, or paper), and the intended user group. The findings were positive, confirming the effectiveness of DAs, in all five cases ( Table 1).

Table 1. Decision aids used directly by pregnant women.

PublicationAuthorCountryDesign FindingsIs the decision aid retrievable? Whether decision aid still in use
Effect of a Patient-Centred Decision Support Tool on Rates of Trial of Labor After Previous Cesarean Delivery.Kuppermann et al.6USARCTUse of the patient-centred decision support tool did not significantly increase trial of labour, VBAC rates, maternal or neonatal outcomes, or decision quality compared with usual care.Screenshots of the PROCEED decision support tool are available in the online supplementary material of the original publication (Supplement 1, eFigure: Selected PROCEED Decision Support Tool Screen Shots).6 https://doi.org/10.1001/jama.2020.5952 No
Response from study author (second email): ‘… the tool is no longer used clinically because its original VBAC calculator relied on race and ethnicity inputs later shown to contribute to disparities in TOLAC/VBAC rates.’
Two decision aids for mode of delivery among women with previous caesarean section: randomised controlled trial.Montgomery et al.7UKRCTBoth decision aids significantly reduced decisional conflict compared with usual care. The information programme improved informed decision-making, while the decision analysis tool showed a higher (though not statistically significant) VBAC rate than usual care.Yes
Link to the decision aid provided by the author. That link has been configured so that only the person who received the email can open it.
No
Response from study author (third email) provided a link to the decision aid. However, the link could only be opened in the recipient of the message’s email and not able to be forwarded.
A randomized comparative trial of two decision tools for pregnant women with prior caesareans. Eden et al.8USARCTBoth the interactive decision aid and educational brochures improved knowledge, reduced decisional conflict, increased feelings of support, and clarified birth priorities. The interactive decision aid provided greater clarification of birth priorities among women in the third trimester, but no clear superiority in delivery outcomes was demonstrated.YesNo
Response from study author – The tool is no longer in use (no ongoing funding), and it is not accessible.
The effect of the use of a decision aid with individual risk estimation on the mode of delivery after a caesarean sectionVankan et al.9NetherlandsProspective CohortThe decision aid did not reduce VBAC rates, but reduced unplanned caesarean sections by approximately 40%, increased elective repeat caesarean sections, and substantially improved women’s involvement in decision-making.Yes
Link to the decision aid provided by the author.
10 (in Dutch) https://www.degynaecoloog.nl/wp-content/uploads/keuzehulp-VBAC-Nederlands.pdf
Yes
Response from one of the study authors. The decision aid has been implemented nationwide in the Netherlands and is used in over 60 hospitals. Both the decision aid and prediction model are generally available, although the 10-year-old decision aid is currently under revision. The prediction model is not certified, and ownership following the initial research phase remains challenging; consequently, it is disseminated and used personally as an Excel tool. Recent concerns about including racial background also necessitate model revision. Although a database is available to rerun the model without racial background, progress is limited by ownership, time, and funding constraints.
Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed-methods pilot study.Humphries et al.11Canada and SpainMixed Method DesignParticipants valued the personalised, evidence-based decision support tool and felt better prepared for consultations. However, some found the standard gamble exercise difficult to understand, and improvements were needed in how personalised recommendations were presented.Yes
Link to the decision aid provided by the author.
The online version11 (https://dathrombosis.trilema.es/dashboard) includes only the information-delivery component.
The tool is not hosted in additional repositories.
No
Response from the study author – ‘To the best of our knowledge, the tool is not currently in use in the original five hospital sites, nor in other clinical or research settings beyond the study itself.
The main reasons it has not been implemented in routine clinical practice are licensing and funding limitations, which have prevented further deployment, updating, and long-term maintenance of the tool.’

Assessing sustainability

The assessment of sustainability was conducted in two stages. First, we assessed retrievability by reviewing the original publication and supplementary files and by searching online for the named decision aid (or an updated version). Second, we assessed continued use in routine practice through direct correspondence with the corresponding or other study authors. Email addresses were located either via the published paper itself, or by using an online search engine (Google) to locate contact information about the research team, for example via the website of the individual’s current university employment. Authors were asked whether the decision aid remained in use, whether it was still accessible, and, if it had been discontinued, the reasons for discontinuation. Follow-up emails were sent where required, with up to three contact attempts made initially. For authors who did not respond to these attempts, further follow-up was undertaken by the research team. Author correspondence was ultimately obtained for all five included decision aids. Where an author response was not initially obtained, we also sought information from the clinical service in which the decision aid had originally been evaluated, using email contacts with clinic staff. Because respondents were investigators associated with the original evaluations rather than designated organisational representatives, their statements about current organisational use were treated as respondent-reported information rather than independently verified organisational data.

Barriers to sustainability

Reasons for continuation or discontinuation were extracted directly from the correspondence and tabulated by decision aid. We used a structured, deductive descriptive approach rather than a qualitative thematic analysis. Reported reasons were first retained in their original substantive form (for example, lack of ongoing funding, licensing restrictions, lack of ownership, or the need to revise an outdated prediction model) and were then mapped to the most relevant domain of the Non-adoption, Abandonment, Scale-up, Spread and Sustainability (NASSS) framework. The mapping was used as an organising framework and was not intended to imply causal attribution beyond what respondents reported. Where a reason could plausibly relate to more than one NASSS domain, its placement reflected the principal mechanism described in the correspondence.

Ethical consideration

No patient-level data were used in this study. The work relied on published literature and professional correspondence with study authors. All communication was carried out using publicly available contact details, and no sensitive or personal information was collected.

Results

Included Studies

Five decision aids (DAs) met our inclusion criteria ( Table 1). These patient-directed DAs spanned: mode of birth after a previous caesarean section (three DAs), thromboprophylaxis during pregnancy (one DA), and preterm labour management (one DA). Geographically, tools originated from the United States (two), the United Kingdom (one), the Netherlands (one), and a Canada-Spain collaboration (one). Publication dates ranged from 2007 to 2023, spanning sixteen years of DA development in maternity care. Three of the studies used randomised designs. Outcomes were of three types: (i) decision makers’ knowledge, (ii) overall satisfaction, and (iii) satisfaction with the decision made. The outcomes measured across the studies were uniformly positive ( Table 1).

Retrievability of decision aids ( Table 1)

Only one of the five decision aids was retrievable electronically9 while another was retrieved by contacting the author.7 The remaining decision aids could not be retrieved. The PROCEED decision aid6 was available only as screenshots within supplementary material and could not be retrieved as a usable tool.

Sustainability of DA in clinical use

Based on the information available at the time of data extraction, one of the five decision aids was reported to remain in routine clinical use: the Dutch tool evaluated by Vankan et al.,9 which an original study author reported had been implemented nationally across more than 60 hospitals in the Netherlands. The same respondent noted that an unspecified number of clinics were no longer using the tool and that the prediction model underpinning the tool required revision which had not been implemented because of financial constraints and lack of clarity over ownership. For the other four decision aids, original study authors or local clinic staff reported that the tools were no longer in use.

Patterns of withdrawal

Respondent-reported reasons for discontinuation or threatened sustainability included absence of ongoing funding, licensing and governance barriers, lack of clear ownership or stewardship, and difficulty maintaining or updating tools when underlying prediction models or clinical expectations changed ( Table 2). These categories represent a deductive mapping of the reasons stated in correspondence to NASSS domains; they should not be interpreted as independently established causes of discontinuation.

Table 2. Mechanisms of withdrawal in five evaluated decision aids, mapped to NASSS framework domains.

NASSS DomainObserved barrier in withdrawn DAsReasonsStudies
Value proposition Insufficient resources to demonstrate long-term organisational value after trial completion.Failure to secure ongoing investment and sustainability beyond the research funding period.Montgomery et al.,7 Eden et al.8
Technology Algorithmic ageing, dependence on outdated prediction models, inclusion of race/ethnicity-based predictors requiring revalidation, and lack of ongoing technical updates.Reduced clinical confidence, concerns regarding fairness and bias, diminished usability, and eventual withdrawal or revision of the decision aid.Vankan et al.9 (prediction model including ethnicity), Kuppermann et al.6 (race-based predictor requiring revision), Humphries et al.11 (technical and usability challenges of personalised decision analysis).
Organisation Lack of institutional ownership and stewardship structures.No mechanism for maintenance, governance, or responsibility for updating the decision aid after completion of the project.Montgomery et al.,7 Eden et al.8
Embedding and adaptation over time Inability to update tools in response to evolving evidence, policy, and clinical practice.Progressive obsolescence and eventual withdrawal or substantial revision of the decision aid.Vankan et al.,9 Kuppermann et al.6

Discussion

This systematic evaluation of the sustainability of maternity-care decision aids identified a pattern of post-study tool attrition. Only one of the five patient-directed decision aids evaluated in RCTs or prospective cohort studies remained accessible and in routine clinical use at the time of this assessment ( Table 1), and even this DA was no longer in use in some of the original sites.

The DAs were not withdrawn because of deficiencies in design or evaluation. For example, the DiAMOND DA underwent a comprehensive programme of research, including protocol development, piloting, a multicentre randomised controlled trial, economic evaluation, and implementation studies.7,12–15 The reason the DAs were not sustained seems to lie in the failure to maintain them; they were added to the system but not incorporated in the system, and they ‘belonged’ to the investigators, not the service managers. For example, two DAs could not be quickly adapted in response to concerns regarding the use of race and ethnicity in clinical prediction algorithms,16 because there was no system in place to maintain and update the DAs. This is in stark contrast to medicines, where systems have evolved to keep the formulary up to date.

Our findings extend and reinforce a pattern identified across the broader decision-aid implementation literature. The Cochrane review notes that implementation and maintenance require explicit attention to barriers and supporting strategies.4 In our evaluation, the only decision aid reported to remain in routine use was the Dutch tool evaluated by Vankan et al.,9 which had spread beyond the original study setting to more than 60 hospitals. Even this example remained vulnerable: the respondent described difficulties concerning ownership and insufficient resources to update the tool. This illustrates that spread does not necessarily equate to secure long-term sustainability.

In some cases, not only was the DA not maintained, but it could not be located, a problem that could be tackled by embedding DAs in the electronic record that have been widely implemented in high-income countries.17

Strengths and limitations

A strength of this evaluation is that direct correspondence with investigators provided information about the post-study status of decision aids that was not consistently available in publications or supplementary materials. However, this source of evidence also requires caution. Study authors were selected because they had direct knowledge of the original decision aid and its evaluation, but they were not necessarily responsible for subsequent implementation or formally authorised to speak for the organisations in which the tools had been used. Their responses therefore provide informed investigator accounts rather than independently verified organisational assessments. We have accordingly distinguished reported status and reported reasons from verified facts throughout the manuscript.

Several limitations merit acknowledgement. First, this evaluation is limited to published, identifiable DAs with traceable authors; tools developed and used outside research contexts, including commercial products, locally produced patient information sheets, or tools embedded in electronic health record systems, are not captured. Second, the findings are concentrated in high-income settings and cannot characterise sustainability in low- and middle-income countries. Third, continued use and reasons for discontinuation were primarily established through investigator correspondence. Although author correspondence was obtained for all five included decision aids, respondents were not systematically identified as organisational implementation leads, service managers, or current tool owners. Consequently, they may not have had complete knowledge of use across all original sites, and we did not independently verify their accounts with every organisation in which a decision aid had been implemented. Fourth, the reasons for withdrawal were collected through focused correspondence rather than prospective interviews or a formal qualitative study; the NASSS classification should therefore be regarded as a deductive descriptive mapping of reported reasons, not as a comprehensive analysis of causal mechanisms. Fifth, the evaluation provides a cross-sectional snapshot, and tool availability may change over time.

Conclusions

This evaluation suggests that demonstrating the effectiveness of a decision aid does not ensure its long-term sustainability in routine maternity care. Four of the five decision aids were reported to be no longer in routine use, with recurrent barriers including lack of funding, ownership, governance, licensing arrangements, and mechanisms for updating tools as evidence and clinical practice evolved. Future decision-aid programmes should therefore consider sustainability from the outset, with explicit arrangements for ownership, maintenance, updating and integration into routine clinical systems.

Ethics approval and consent to participate

Not applicable. This study did not involve patients, patient-level data, human tissue, or identifiable personal data. The study was based on published literature and professional correspondence with study authors using publicly available contact details.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 28 Oct 2026
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
VIEWS
53
 
downloads
2
Citations
CITE
how to cite this article
Tariq S, Nayyar P, Carroll F and Lilford R. Are Maternal Decision Aids sustained in the centre where they had been found to be effective? [version 1; peer review: awaiting peer review]. NIHR Open Res 2026, 6:193 (https://doi.org/10.3310/nihropenres.14466.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status:
AWAITING PEER REVIEW
AWAITING PEER REVIEW
?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 28 Oct 2026
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions

Are you an NIHR-funded researcher?

If you are a previous or current NIHR award holder, sign up for information about developments, publishing and publications from NIHR Open Research.

You must provide your first name
You must provide your last name
You must provide a valid email address
You must provide an institution.

Thank you!

We'll keep you updated on any major new updates to NIHR Open Research

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.